Skip to main content
CDC Website

HIV/AIDS

MMWR: HIV Surveillance - United States, 1981-2008

This report summarizes results of CDC’s analysis of data from the National HIV Surveillance System on the 30th anniversary of the HIV/AIDS epidemic. The report characterizes trends in HIV infection and AIDS in the United States during 1981-2008. Results indicate that in the first 14 years, sharp increases were reported in the number of new AIDS diagnoses and deaths reaching highs of 75,457 in 1992 and 50,628 in 1995. However with the introduction of highly active antiretroviral therapy, AIDS diagnoses and deaths declined substantially from 1995-1998, and remained stable from 1999-2008.

MMWR: HIV Testing Among Men Who Have Sex With Men - 21 Cities, United States, 2008

This report describes the results of CDC’s analysis of HIV testing conducted in 21 cities as part of the National HIV Behavioral Surveillance System (NHBS) to assess whether MSM were tested as recommended (at least annually) and whether more frequent testing was indicated. Results indicated that of 7,271 MSM interviewed and tested, who had not reported a previous positive HIV test, 61 percent had been tested during the past 12 months. Of these, seven percent had a new, positive HIV test result when tested as part of NHBS.

MMWR: Clinical and Behavioral Characteristics of Adults Receiving Medical Care for HIV Infection–Medical Monitoring Project, United States, 2007

This serial reports on the Medical Monitoring Project (MMP). The MMP was designed to be a nationally representative, population-based surveillance system to assess clinical outcomes and behavioral outcomes among persons with HIV infection who are receiving medical care in the United States. This report covers data collected during June 2007 to September 2008 for patients who received medical care in 2007. Findings indicate that in 2007, most persons with HIV infection who were receiving medical care were taking antiretroviral therapy (ART), and had some form of health insurance or coverage.

MMWR: Vital Signs: HIV Infection, Testing, and Risk Behaviors Among Youths - United States

In this report, the CDC used the National HIV Surveillance System data to estimate among youths, prevalence rates of diagnosed HIV infection in 2009 and the number of new infections in 2010. CDC used the 2009 and 2010 Youth Risk Behavior Surveillance System for 9th -12th grade students and the 2010 National Health Interview Survey for persons 18-24 years. Prevalence of diagnosed HIV was 69.5 per 100,000 youths at the end of 2009. Youth accounted for 12,200 (25.7 percent) new HIV infections in 2010.

Speed Up Scale Up: Strategies, Tools and Policies to Get the Best HIV Treatment to More People, Sooner

This report outlines some of the strategies, tools and policies that have supported the scaling up of treatment during the past decade as well as those that can address persistent or new challenges. The results are presented from a 23-country survey of how consistently these strategies are being implemented. The findings demonstrate encouraging progress by some health ministries in adopting many of the enabling policies needed to facilitate scale-up and improve care. Nevertheless, the adoption and implementation of these strategies, tools and policies are lagging in some countries.

Surveillance Brief: Terms, Definitions, and Calculations Used in CDC HIV Surveillance Publications

This information sheet explains terms, definitions, and methods of calculation used in HIV surveillance data, and the uses of these data. It defines unadjusted data, adjusted (estimated) data, AIDS diagnoses and deaths of persons with an AIDS diagnoses, and diagnoses of HIV infection and deaths of persons with a diagnosis of HIV infection. It also defines HIV incidence, persons living with a diagnosis of HIV infection or AIDS, incidence rate, prevalence rate, stage of disease, and transmission category.

Adverse Events of Antiretroviral Drugs

This internet electronic file discusses side effects of antiretroviral therapy for persons with HIV. The file provides information in table form on the most common adverse events for each of the five types of antiretroviral drugs.
Was this page helpful? Give Feedback